Meeting
2020 Gastrointestinal Cancers Symposium
Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217.
Authors
Gunnar Folprecht
University Hospital Carl Gustav Carus, Dresden, Germany
Gunnar Folprecht , Anke Reinacher-Schick , Andrea Tannapfel , Juergen Weitz , Thibaud Kossler , Lukas Weiss , Daniela Ellen Aust , Nikolas von Bubnoff , Michael Kramer , Christian Thiede
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT04089631
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr TPS273)
Abstract #
TPS273
Poster Bd #
N7
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah
Poster
2019 ASCO Annual Meeting
POLEM: Avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III dMMR or POLE exonuclease domain mutant colon cancer—A phase III randomized study.
First Author: David Lau
Poster
2018 Gastrointestinal Cancers Symposium
Early survival outcomes in stage I-III operated colon cancer patients from a low prevalence, lower-middle income country: The Indian experience.
First Author: Rushabh Kiran Kothari
Poster
2018 Gastrointestinal Cancers Symposium
Clinical impact of diverting ileostomy on the dose intensity of adjuvant chemotherapy for colorectal cancer.
First Author: Shusuke Yagi